Staphylococcus aureus wall teichoic acid and peptidoglycan (WTA-PG)

Staphylococcus aureus wall teichoic acids (WTA) and peptidoglycan (PG) constitute the fundamental structural scaffold of the Gram-positive bacterial cell wall (Brown et al., 2013, Nature Reviews Microbiology). Peptidoglycan is a cross-linked polymer of amino acids and sugars that provides structural rigidity and protects the cell from osmotic lysis, while WTAs are phosphate-rich glycopolymers covalently attached to the peptidoglycan layer (Swoboda et al., 2010, ChemBioChem). These components are critical for bacterial physiology, playing essential roles in cell shape maintenance, antibiotic resistance, and the regulation of cell division (Campbell et al., 2011, ACS Chemical Biology). In the context of pathogenesis, they facilitate adhesion to host surfaces and contribute to immune evasion by modulating host inflammatory responses (Xia et al., 2010, International Journal of Medical Microbiology). As these structures are absent in humans, they represent highly selective targets for antimicrobial agents. Classic antibiotics like glycopeptides and beta-lactams target peptidoglycan assembly, while novel inhibitors targeting WTA biosynthesis are being explored to overcome multi-drug resistance in strains like MRSA (Gerits et al., 2017, Molecules). The interplay between WTA and PG is also vital for the localization of proteins involved in cell wall metabolism and virulence. Consequently, disrupting this complex not only kills the bacteria but can also restore sensitivity to other antibiotics.

Other names

Staphylococcus aureus cell wallWall teichoic acidPeptidoglycanMureinBacterial cell wall glycopolymersTeichoic acid-peptidoglycan complex

Inhibition of peptidoglycan cross-linking by binding to D-alanyl-D-alanine precursors or inhibiting transpeptidase enzymes, and inhibition of wall teichoic acid biosynthesis enzymes such as TarO and TarG (Brown et al., 2013; Campbell et al., 2011).